Business

TPT Global Tech's Subsidiary "TPT MedTech" Announced today the Launch of Two New Products and Services, Its Mobile "QuikLAB" Testing, Vaccination and Monitoring APP and Its "QuikPASS" Check and Verify APP. "QuikPASS" will be FREE to the US and Internation

TPT Global Tech's Subsidiary "TPT MedTech" Announced today the Launch of Two New Products and Services, Its Mobile "QuikLAB" Testing, Vaccination and Monitoring APP and Its "QuikPASS" Check and Verify APP. "QuikPASS" will be FREE to the US and Internation.

articleTpt Global Tech, Inc.December 21, 20203/company/tpt-global-tech-inc/news/tpt-global-techs-subsidiary-tpt-medtech-announced-today-the-launch-of-two-new-products-and-services-its-mobile-quiklab-testing-vaccination-and-monitoring-app-and-its-quikpass-check-and-verify-app-quikpass-will-be-free-to-the-us-and-internation
TPT Global Tech's Subsidiary "TPT MedTech" Announced today the Launch of Two New Products and Services, Its Mobile "QuikLAB" Testing, Vaccination and Monitoring APP and Its "QuikPASS" Check and Verify APP. "QuikPASS" will be FREE to the US and Internation

About this update from Tpt Global Tech, Inc.

[{"type":"text","content":"SAN DIEGO, CA / ACCESSWIRE / December 21, 2020 / TPT Global Tech Inc. (OTCQB:TPTW) www.tptglobaltech.com based in San Diego, California, is a technology-based company with divisions providing telecommunications, medical technology, media content for domestic and international syndication as well as technology solutions. It offers carrier-grade performance and support for consumers and businesses over its private fiber and wireless network throughout the United States. Today the company announced it had released two new products and services for use at its TPT Med Tech division. First, its "QuikLAB" App product which was designed for use in monitoring patients testing and vaccination history, and second, "QuikPASS". The "QuikPASS" Mobile APP was designed to allow entrance to any facility or country based on patient test and vaccination results on a real time basis worldwide. The QuikPASS will be offered "FREE" to the US and International Consumer markets. The company will license the "QuikLAB" network to companies and Partner labs and testing organizations around to Globe on a monthly licensing fee and a per Covid 19 test fee.Being a Technology company TPT observed the Covid 19 pandemic from a different viewpoint, the company sees it as a technical issue as well as medical. TPTW understood from the very beginning that there would be a need for technology to help us out of this serious pandemic. The company immediately pivoted into the Medical sector launching its TPT MedTech division www.tptmedtech.com. TPT MedTech's core product lines are our "QuikLAB", "QuikPASS" and "SaniQUIK" End to End streamline COVID-19 testing and verifying technology platforms with, 1, scalable on site medical grade labs that come to offices/venues to conduct testing, 2, a fully online HIPAA Compliant App to share when a customer needs to provide proof that they've tested negative/positive and/or if they've been vaccinated, and, 3, mobile sanitizing cabins (organic/safe, takes 240 people/hour with a 1 second thermal scan) to insure that individuals are not carrying the virus on their exterior clothing.The company's belief is that we as a country need to do more testing, but once that testing is complete there needs to be a HIPPA compliant centralized platform ...

More updates from Tpt Global Tech, Inc.